Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Merino

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Revista Medica De Chile|January 6, 2005
[A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]Rogelio P González, Ricardo M Gómez, René S Castro, et al.
Transboundary and Emerging Diseases|March 5, 2014
Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogensJ de la Fuente, J A Moreno-Cid, R C Galindo, et al.
Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.
Journal of Crohn'S & Colitis|September 11, 2013
Disease severity in familial cases of IBDM Andreu, L Márquez, E Domènech, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2021
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE studyG Bastida, I Marín-Jiménez, A Forés, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Revista Medica De Chile|January 6, 2005
[A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]Rogelio P González, Ricardo M Gómez, René S Castro, et al.
Transboundary and Emerging Diseases|March 5, 2014
Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogensJ de la Fuente, J A Moreno-Cid, R C Galindo, et al.
Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.
Journal of Crohn'S & Colitis|September 11, 2013
Disease severity in familial cases of IBDM Andreu, L Márquez, E Domènech, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2021
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE studyG Bastida, I Marín-Jiménez, A Forés, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
Pageof 4